Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care

Published by Professor Simon Bell on Apr 24, 2024

Disclaimer

Sponsors

Contact

Abstract

Language

en-au

PICOS

PICO 8.1

Population
People living with dementia
Intervention
Second generation antipsychotics
Comparator
Placebo
Outcomes

PICO 8.2

Population
People living with dementia
Intervention
First generation antipsychotic
Comparator
Placebo
Outcomes

PICO 8.3

Population
People living with dementia
Intervention
First generation antipsychotics
Comparator
Second generation antipsychotics
Outcomes

PICO 9.1

Population
People living with dementia using antipsychotics
Intervention
Discontinuation of antipsychotic medication
Comparator
Continuation of antipsychotic medication
Outcomes

PICO 10.1

Population
People living with dementia
Intervention
Benzodiazepines
Comparator
No treatment or placebo
Outcomes

PICO 11.1

Population
People living with dementia
Intervention
Discontinuation of benzodiazepines
Comparator
Continuation of benzodiazepines
Outcomes

PICO 12.1

Population
People living with dementia
Intervention
Antidepressants
Comparator
Placebo
Outcomes

PICO 13.1

Population
People living with dementia
Intervention
Discontinuation of antidepressants
Comparator
Continuation of antidepressants
Outcomes

PICO 14.1

Population
People living with dementia
Intervention
Pro re nata (PRN) use of antipsychotics
Comparator
Regular use of antipsychotics
Outcomes

PICO 15.1

Population
RACF residents
Intervention
Professional Education Program
Comparator
No intervention/usual care/control
Outcomes

PICO 15.2

Population
RACF residents
Intervention
Medication Review
Comparator
No intervention/usual care/control
Outcomes